Skip to main content

CME GROUP INC.

For the period ended Jun 30, 2025. Filed Jul 25, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2025 · Filed Jul 25, 2025

CME$309.09+1.5%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Unregistered Sales of Equity Securities and Use of Proceeds

ITEM 2.UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

Issuer Purchases of Equity Securities

Period · Total Number ofClass AShares Purchased · Average PricePaid per Share · Total Number of Class A Shares Purchased asPart of Publicly Announced Plans or Programs (1) · Maximum Approximate Value of Shares ThatMay Yet Be PurchasedUnder the Plans or Programs(in millions)
April 1 to April 3032,866(2)$253.5132,265$2,991.8
May 1 to May 3177(3)271.70—2,991.8
June 1 to June 301,776(3)269.66—2,991.8
Total34,719(4)32,265

(1)On December 5, 2024, CME Group announced that its board of directors approved a share repurchase program under which CME Group is authorized to repurchase up to $3.0 billion of its outstanding Class A common stock, par value $0.01 per share (the common stock). The share repurchase program has no expiration date.

(2)Includes 601 shares of Class A common stock surrendered to satisfy employees' tax obligations upon the vesting of restricted stock.

(3)Consists solely of shares of Class A common stock surrendered to satisfy employees' tax obligations upon the vesting of restricted stock.

(4)Includes 2,454 shares of Class A common stock surrendered to satisfy employees' tax obligations upon the vesting of restricted stock.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.